Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Some ways to handle risk in current macro environment

Friday, December 21, 2012

Benedicte Gravrand, Opalesque Geneva:

There are many ways to deal with risk and tail-risk. But in the current environment, one must be even more creative. Participants at the recent Opalesque Geneva Roundtable discussed some of their risk management methods, such as the use of derivative-driven insurance strategies, beta management, approved tail-risk managers and overlay programs, a benchmark-agnostic approach, a larger allocation to sovereign bonds, stress risk measures, and segregated accounts.

Tail-risk is on both sides of the distribution in the current macro environment, said Gregoire Haenni, CIO of the CERN Pension Fund. On the one hand, there are stimulus programs going on in developed markets, and on the other, those same markets are facing fiscal tightening. Growth figures early next year will be disappointing and equities market could drop too. He believes that credit strategies may do well if they’re well dynamically managed as well as risk managed. For tail risk protection at CERN, he added, "we implemented ourselves some mainly derivative-driven insurance strategies. But, we also actively manage the beta of the portfolio."

Mercer has a list of approved tail-risk managers and overlay programs which they implement with various institutions, Dominique Grandchamp, Senior Investment Consultant at Mercer, told the participants. But tail-risk programs do not address the r......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its